1. Home
  2. OLP vs ALVOW Comparison

OLP vs ALVOW Comparison

Compare OLP & ALVOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLP
  • ALVOW
  • Stock Information
  • Founded
  • OLP 1982
  • ALVOW 2013
  • Country
  • OLP United States
  • ALVOW Luxembourg
  • Employees
  • OLP N/A
  • ALVOW 999
  • Industry
  • OLP Real Estate Investment Trusts
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OLP Real Estate
  • ALVOW Health Care
  • Exchange
  • OLP Nasdaq
  • ALVOW Nasdaq
  • Market Cap
  • OLP N/A
  • ALVOW N/A
  • IPO Year
  • OLP N/A
  • ALVOW N/A
  • Fundamental
  • Price
  • OLP $25.60
  • ALVOW $2.34
  • Analyst Decision
  • OLP Strong Buy
  • ALVOW
  • Analyst Count
  • OLP 1
  • ALVOW 0
  • Target Price
  • OLP $28.00
  • ALVOW N/A
  • AVG Volume (30 Days)
  • OLP 40.9K
  • ALVOW 15.0K
  • Earning Date
  • OLP 03-04-2025
  • ALVOW 02-27-2025
  • Dividend Yield
  • OLP 7.03%
  • ALVOW N/A
  • EPS Growth
  • OLP 51.11
  • ALVOW N/A
  • EPS
  • OLP 1.63
  • ALVOW N/A
  • Revenue
  • OLP $89,142,000.00
  • ALVOW $393,919,000.00
  • Revenue This Year
  • OLP N/A
  • ALVOW N/A
  • Revenue Next Year
  • OLP $4.71
  • ALVOW N/A
  • P/E Ratio
  • OLP $15.71
  • ALVOW N/A
  • Revenue Growth
  • OLP N/A
  • ALVOW 517.92
  • 52 Week Low
  • OLP $19.90
  • ALVOW $2.33
  • 52 Week High
  • OLP $30.45
  • ALVOW $2.33
  • Technical
  • Relative Strength Index (RSI)
  • OLP 42.57
  • ALVOW N/A
  • Support Level
  • OLP $25.52
  • ALVOW N/A
  • Resistance Level
  • OLP $26.49
  • ALVOW N/A
  • Average True Range (ATR)
  • OLP 0.42
  • ALVOW 0.00
  • MACD
  • OLP 0.04
  • ALVOW 0.00
  • Stochastic Oscillator
  • OLP 27.05
  • ALVOW 0.00

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: